Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Xiao-Tao Yao"'
Autor:
Kevin Schifferli, Gordon Moody, Karma Dacosta, Nina Chu, Ryan Gilbreth, Lori Clarke, Christina Gesse, Letizia Giardino, Cui Chen, Erin Sult, Noel Monks, Ravinder Tammali, Jon Chesebrough, Jessica Tong, Xiao-Tao Yao, Kapil Vashisht
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/4c51e28240674a9e93fe3715949db0c1
Publikováno v:
Journal of Orthopaedic Surgery and Research, Vol 13, Iss 1, Pp 1-9 (2018)
Abstract Background Posterior short-segment pedicle screw fixation is used to treat thoracolumbar burst fractures. However, no randomized controlled studies have compared the efficacy of the two approaches––the Wiltse’s paraspinal approach and
Externí odkaz:
https://doaj.org/article/137eb08b14ac4e1cb35bcc91000c3fde
Publikováno v:
网络与信息安全学报, Vol 8, Iss 6, Pp 70-83 (2022)
The vehicular cloud (VC) formed by vehicles is used for localization processing and consumption of traffic sensing data to achieve timely intelligent traffic management.The vehicle cloud is highly dynamic, self-organizing and timely, in which the ide
Externí odkaz:
https://doaj.org/article/8f52ea9cbf2648ef8adafbdd1ec6a1bf
Publikováno v:
Progress In Electromagnetics Research Letters. 109:57-63
Publikováno v:
Progress in Electromagnetics Research C; 2023, Vol. 136, p51-60, 10p
Autor:
Maria Letizia Giardino Torchia, Ryan Gilbreth, Ashley Merlino, Erin Sult, Noel Monks, Jon Chesebrough, Ravinder Tammali, Nina Chu, Jessica Tong, John Meekin, Kevin Schifferli, Kapil Vashisht, Karma DaCosta, Lori Clarke, Christina Gesse, Xiao-Tao Yao, Courtney Bridges, Gordon Moody
Publikováno v:
Cytotherapy. 24(7)
Chimeric antigen receptor (CAR) T cell therapy has yielded impressive clinical results in hematological malignancies and is a promising approach for solid tumor treatment. However, toxicity, including cytokine-release syndrome (CRS) and neurotoxicity
Autor:
Nina Chu, Kevin Schifferli, Gordon Moody, Christina Gesse, Jon Chesebrough, Noel R. Monks, Letizia Giardino, Lori A. Clarke, Xiao-Tao Yao, Erin Sult, Kapil Vashisht, Karma Dacosta, Cui Chen, Jessica Tong, Ravinder Tammali, Ryan Gilbreth
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Background Chimeric antigen receptor (CAR)-T therapy has yielded impressive clinical results in hematological malignancies and it is a promising approach for solid tumor treatment. However, toxicity, including on-target off-tumor antigen binding, is
Autor:
Ernie Boyd, Rutul R. Shah, Shashi Kaithamana, Geping Wang, Spandana Kankanala, Viktor Roschke, Xiao-Tao Yao, David M. Hilbert, Viktoriya Nam, Rodger Smith, Pete Buasen, Carlos F. Barbas, Liubov Zaritskaya, Peter Kiener, Bridget A. Puffer, Donara Abramyan, Rajesh Krishnamurthy, Palanisamy Kanakaraj, David W. Lafleur, Andrew F. Burnette, Dimki R. Patel
Publikováno v:
mAbs. 5:208-218
The recognition that few human diseases are thoroughly addressed by mono-specific, monoclonal antibodies (mAbs) continues to drive the development of antibody therapeutics with additional specificities and enhanced activity. Historically, efforts to
Autor:
David M. Hilbert, Palanisamy Kanakaraj, Carlos F. Barbas, Peter Kiener, Xiao-Tao Yao, Rodger Smith, Rutul R. Shah, Bridget A. Puffer, David W. Lafleur, Geping Wang, Dimki R. Patel, Ernest Boyd, Shashi Kaithamana, Spandana Kankanala, Viktor Roschke, Rajesh Krishnamurthy
Publikováno v:
mAbs
Despite the clinical success of anti-tumor necrosis factor (TNF) therapies in the treatment of inflammatory conditions such as rheumatoid arthritis, Crohn disease and psoriasis, full control of the diseases only occurs in a subset of patients and the
Autor:
Peter A. Kiener, Ryan Fleming, Herren Wu, Lena Shirinian, Robert M. Woods, Xiao-Tao Yao, Changshou Gao, Nazzareno Dimasi
Publikováno v:
Journal of Molecular Biology. 393:672-692
Monoclonal antibodies are traditionally used to block the function of a specific target in a given disease. However, some diseases are the consequence of multiple components or pathways and not the result of a single mediator; thus, blocking at a sin